Our systems are now restored following recent technical disruption, and we’re working hard to catch up on publishing. We apologise for the inconvenience caused. Find out more

Item added to bagSorry, there was a problem getting your bag informationItem cannot be purchased with the existing contents of your bagItem unavailable online
✕

was added to your bag.

Please try again.

Sorry, this item cannot be purchased in the same transaction as the existing items in your bag.

Please complete the purchase of the items currently in your bag and then add this item in a separate transaction or visit Shopping Help.

Sorry, this product is not currently available to buy online. Please visit Shopping Help.

View bag and checkout
Remove item
✕

Are you sure you want to remove from your bag?

Recommended product

Popular links

Popular links

Small Molecule Therapy for Genetic Disease

All titles
Small Molecule Therapy for Genetic Disease

Small Molecule Therapy for Genetic Disease

Jess G. Thoene, University of Michigan, Ann Arbor
September 2010
This ISBN is for an eBook version which is distributed on our behalf by a third party.
Adobe eBook Reader
9780511910890
$104.00
USD
Adobe eBook Reader
USD
Hardback
✕

You are now leaving the Cambridge University Press & Assessment website. Your ebook purchase and download will be completed by our partner www.ebooks.com. Please see the permission section of the www.ebooks.com catalogue page for details of print and copy limits of our ebook.

Continue
    Description

    Thoene summarises the substantial work that has been accomplished in the treatment of inborn errors of metabolism with simple molecules. This handbook will enable interested clinician scientists to rapidly survey the field, thus ascertaining what has been done as well as future directions for therapeutic research. Its important introductory chapters discuss the infrastructure of the field. The book closely analyses the cofactors used to augment the function of defective enzymes and the compounds that are able to utilise an alternative pathway in order to avoid the consequences of the metabolic block present in the patient. Among other therapies, the authors discuss the use of zinc and tetrathiomolybdate to treat Wilson's disease and the use of cysteamine to treat nephropathic cystinosis.

    • First book in 15 years which concentrates on state of the art therapy for metabolic disorders
    • Contains section on the FDA of orphan products written by Dr Marlene Haffner, the second director of the FDA Office
    • Contains detailed section on the operations of the National Institutes of Health Office of Rare Diseases written by the director, Stephen Groft

    Product details

    September 2010
    Adobe eBook Reader
    9780511910890
    0 pages
    0kg
    31 b/w illus. 18 tables
    This ISBN is for an eBook version which is distributed on our behalf by a third party.

    Often bought together

    Regenerative Pharmacology
    Regenerative Pharmacology

    : Hardback

    Drug Design
    Drug Design

    : Hardback

    Structure- and Ligand-Based Approaches

    Principles of Translational Science in Medicine
    Principles of Translational Science in Medicine

    : Hardback

    From Bench to Bedside

    A Treatise of the Scurvy, in Three Parts
    A Treatise of the Scurvy, in Three Parts

    : Paperback

    Containing an Inquiry into the Nature, Causes, and Cure, of that Disease

    Often bought together

    This title is available for institutional purchase via Cambridge Core

    Learn more
    cambridge core banner

    Related Journals

    Quarterly Reviews of Biophysics
    Quarterly Reviews of Biophysics

    : Journal

    Quarterly Reviews of Biophysics (QRB) covers the whole field of biophysics, from ion channels to DNA topology and from X-ray diffraction to NMR. The journal has gained a worldwide reputation, demonstrated by its high ranking in the ISI Science Citation Index, as a forum for general and specialised communication between biophysicists working in different areas. The journal features authoritative Reviews, the majority of which are invited from authors who have made significant contributions to the field, and who give critical, readable and sometimes controversial accounts of recent progress and problems in their speciality. The newly founded Discovery section publishes key Open Access original research and what may be described as true discoveries, or novel methods to reach mechanistic understanding of biological systems. While biophysics can be reasonably widely interpreted, to include areas like structural biology, our papers should be firmly anchored with a molecular view of the science.

    Plant Genetic Resources
    Plant Genetic Resources

    : Journal

    Plant Genetic Resources is an international journal which provides a forum for describing the application of novel genomic technologies, as well as their integration with established techniques, towards the understanding of the genetic variation captured in both in situ and ex situ collections of crop and non-crop plants; and for the airing of wider issues relevant to plant germplasm conservation and utilisation. We particularly welcome multi-disciplinary approaches that incorporate both a technical and a socio-economic focus. Technical aspects can cover developments in technologies of potential or demonstrated relevance to the analysis of variation and diversity at the phenotypic and genotypic levels; the development of rational germplasm collection, evaluation and conservation strategies; and the impact of crop genetic modification and biotechnology on plant genetic resources. Non-technical aspects can include ethical, legal, commercial and social issues of relevance, in particular relating to farmers’ rights, intellectual property and ethnobotany.

    Parasitology
    Parasitology

    : Journal

    Parasitology is an important specialist journal covering the latest advances in the subject. It publishes original research and review papers on all aspects of parasitology and host-parasite relationships, including the latest discoveries in parasite biochemistry, molecular biology and genetics, ecology and epidemiology in the context of the biological, medical and veterinary sciences. Included in the subscription price are two special issues which contain reviews of current hot topics, one of which is the proceedings of the annual Symposia of the British Society for Parasitology, while the second, covering areas of significant topical interest, is commissioned by the editors and the editorial board.

    Related Journals

    Also by this Author

    Contents

    Table of Contents

    • 1. FDA and the regulation of small molecules for orphan diseases Marlene Haffner and Tan Nguyen
    • 2. The office of rare diseases research: serving a coordinating function at the national institutes of health Stephen C. Groft
    • 3. Introduction to pharmacokinetics and pharmacodynamics Juan J. L. Lertora and Konstantina M. Vanevski
    • 4. Biotin and biotin-responsive disorders Barry Wolf and Kirit Pindolia
    • 5. Cobalamin treatment of methylmalonic acidemias Hans C. Andersson
    • 6. Sapropterin treatment of phenylketonuria Barbara K. Burton
    • 7. L-carnitine therapy in primary and secondary carnitine deficiency disorders Susan C. Winter, Brian Schreiber and Neil R. M. Buist
    • 8. Cysteamine treatment of nephropathic cystinosis Jess Thoene
    • 9. Nitisinone use in hereditary tyrosinemia and alkaptonuria William A. Gahl, Wendy J. Introne and Kevin O'Brien
    • 10. Alternative waste nitrogen disposal agents for urea cycle disorders Gregory M. Enns
    • 11. PDMP based glucosylceramide synthesis inhibitors for Gaucher and Fabry disease James A. Shayman
    • 12. Betaine treatment for the homocystinurias Harvey L. Levy and Amy Lawson-Yuen
    • 13. Zinc and tetrathiomolybdate for the treatment of Wilson's disease George J. Brewer
    • 14. Small copper complexes for treatment of ATP7A-related disorders Stephen G. Kaler.
      • Show more
    Courses
    Resources
    Additional Information
    About the authors
      Contributors

    • Marlene E. Haffner, Tan Nguyen, Stephen C. Groft, Juan J. L. Lertora, Konstantina M. Vanevski, Barry Wolf, Kirit Pindolia, Hans C. Andersson, Barbara K. Burton, Susan C. Winter, Brian Schreiber, Neil R. M. Buist, Jess G. Thoene, William A. Gahl, Wendy J. Introne, Kevin O'Brien, Gregory M. Enns, James A. Shayman, Harvey L. Levy, Amy Lawson-Yuen, George J. Brewer, Stephen G. Kaler

      • Editor
    • Jess G. Thoene , University of Michigan, Ann Arbor

      Dr Jess G. Thoene is currently Director of the Biochemical Genetics Laboratory in the Division of Pediatric Genetics at the University of Michigan in Ann Arbor and an Active Emeritus Professor of Pediatrics. He has held positions in numerous organizations, including Director of the Hayward Center for Human Genetics at Tulane University Health Sciences Center; Fellow and Medical Director of the Joseph P. Kennedy, Jr Foundation; member of the Board of Directors of Copley Pharmaceuticals; and Chairman of the Board of Directors of the National Organization for Rare Disorders. He has authored numerous articles on inborn errors of metabolism, holds three U.S. patents, and is certified in pediatrics and clinical biochemical genetics.

    Browse by related subject

     
    ✕

    Sorry, this item cannot be purchased in the same transaction as the existing items in your cart.

    Please complete the purchase of the items currently in your cart and then add this item in a separate transaction or contact

    Customer Services